AMERIPRISE FINANCIAL INC - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 162 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.89 and the average weighting 0.0%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$907,000
-39.7%
714,213
+3.5%
0.00%
Q3 2021$1,504,000
-43.1%
690,113
-2.0%
0.00%
-100.0%
Q2 2021$2,641,000
+26.7%
704,416
+10.1%
0.00%0.0%
Q1 2021$2,085,000
+0.2%
639,614
+4.9%
0.00%0.0%
Q4 2020$2,080,000
-29.1%
609,987
-15.1%
0.00%0.0%
Q3 2020$2,934,000
+42.2%
718,874
+17.8%
0.00%0.0%
Q2 2020$2,064,000
+62.1%
610,426
+11.7%
0.00%0.0%
Q1 2020$1,273,000
-40.1%
546,263
-6.4%
0.00%0.0%
Q4 2019$2,124,000
-57.2%
583,689
-2.5%
0.00%
-50.0%
Q3 2019$4,965,000
-2.9%
598,599
+0.8%
0.00%0.0%
Q2 2019$5,112,000
-20.3%
593,713
-1.1%
0.00%
-33.3%
Q1 2019$6,415,000
+24.5%
600,158
+1.9%
0.00%0.0%
Q4 2018$5,153,000
-46.5%
588,743
+2.7%
0.00%0.0%
Q3 2018$9,627,000
-13.6%
573,011
+7.8%
0.00%
-40.0%
Q2 2018$11,143,000
+45.9%
531,636
+12.0%
0.01%
+66.7%
Q1 2018$7,637,000
-13.1%
474,626
+2.3%
0.00%
-25.0%
Q4 2017$8,788,000
+57.6%
463,756
+17.0%
0.00%
+33.3%
Q3 2017$5,576,000
+98.6%
396,331
+5.3%
0.00%
+200.0%
Q2 2017$2,807,000
+14.7%
376,275
-0.0%
0.00%0.0%
Q1 2017$2,447,000
+55.6%
376,385
+6.0%
0.00%0.0%
Q4 2016$1,573,000
-3.8%
354,980
+1.4%
0.00%0.0%
Q3 2016$1,635,000
-15.7%
350,086
+18.6%
0.00%0.0%
Q2 2016$1,939,000
+9.6%
295,069
+6.1%
0.00%0.0%
Q1 2016$1,769,000
+6.1%
278,214
+0.7%
0.00%0.0%
Q4 2015$1,667,000
-3.4%
276,405
-4.2%
0.00%0.0%
Q3 2015$1,726,000
-15.6%
288,594
-3.4%
0.00%0.0%
Q2 2015$2,044,000
+20.0%
298,727
+6.4%
0.00%0.0%
Q1 2015$1,703,000
-12.6%
280,643
-0.2%
0.00%0.0%
Q4 2014$1,949,000
-12.6%
281,172
+2.6%
0.00%0.0%
Q3 2014$2,230,000
+17.4%
274,108
+17.3%
0.00%0.0%
Q2 2014$1,900,000
+9.3%
233,770
+5.4%
0.00%0.0%
Q1 2014$1,738,000
-7.8%
221,710
+4.0%
0.00%0.0%
Q4 2013$1,885,000
+9.5%
213,110
+3.9%
0.00%0.0%
Q3 2013$1,721,000
+18.3%
205,087
+5.2%
0.00%0.0%
Q2 2013$1,455,000195,0120.00%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Consonance Capital Management LP 2,020,583$15,053,0001.77%
Piermont Capital Management Inc. 247,882$1,847,0000.53%
BARD ASSOCIATES INC 129,380$964,0000.44%
Sonora Investment Management, LLC 239,202$1,782,055,0000.34%
TFS CAPITAL LLC 97,526$727,0000.28%
Alambic Investment Management, L.P. 165,001$1,229,0000.15%
KENNEDY CAPITAL MANAGEMENT LLC 491,075$3,659,0000.07%
Renaissance Technologies 6,071,817$45,235,0000.06%
Granite Investment Partners, LLC 97,023$723,0000.05%
ClariVest Asset Management LLC 241,909$1,802,0000.04%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders